Russell Investments Group Ltd. Increases Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Russell Investments Group Ltd. increased its stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 41,806.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,051 shares of the company’s stock after acquiring an additional 66,891 shares during the period. Russell Investments Group Ltd. owned approximately 0.15% of KORU Medical Systems worth $258,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Calamos Advisors LLC bought a new stake in shares of KORU Medical Systems in the 4th quarter valued at approximately $250,000. White Pine Capital LLC lifted its position in KORU Medical Systems by 25.6% in the fourth quarter. White Pine Capital LLC now owns 157,917 shares of the company’s stock worth $608,000 after buying an additional 32,176 shares during the last quarter. Raymond James Financial Inc. purchased a new position in KORU Medical Systems during the fourth quarter worth $118,000. Geode Capital Management LLC increased its position in KORU Medical Systems by 6.5% during the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after acquiring an additional 28,323 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of KORU Medical Systems in the fourth quarter valued at $104,000. 58.60% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Craig Hallum lifted their price target on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, January 17th. Piper Sandler reaffirmed a “neutral” rating and set a $4.50 target price on shares of KORU Medical Systems in a research note on Friday, February 14th. Lake Street Capital raised their price target on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. Finally, B. Riley upgraded KORU Medical Systems to a “strong-buy” rating in a report on Thursday, March 13th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $4.70.

KORU Medical Systems Stock Performance

Shares of NASDAQ:KRMD opened at $2.49 on Friday. The firm’s 50 day simple moving average is $2.83 and its 200-day simple moving average is $3.37. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. KORU Medical Systems, Inc. has a one year low of $1.86 and a one year high of $5.05. The firm has a market cap of $114.43 million, a PE ratio of -9.96 and a beta of 0.87.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.